Home
/
Harvard Apparatus Regenerative Technology, Inc.
/
Financials
/
Quarterly
Harvard Apparatus Regenerative Technology, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2022
Jun 30, 2022
$0
Aug 4, 2022
Q1
2022
Mar 31, 2022
$0
May 16, 2022
Q3
2021
Sep 30, 2021
$0
Nov 15, 2021
Q2
2022
Jun 30, 2021
$0
Aug 4, 2022
Q1
2022
Mar 31, 2021
$0
May 16, 2022
Q3
2021
Sep 30, 2020
$0
Nov 15, 2021
Q2
2021
Jun 30, 2020
$0
Aug 13, 2021
Q1
2021
Mar 31, 2020
$0
May 24, 2021
Q3
2020
Sep 30, 2019
$0
Nov 13, 2020
Q2
2020
Jun 30, 2019
$0
Aug 13, 2020
Q1
2020
Mar 31, 2019
$0
May 14, 2020
Q3
2019
Sep 30, 2018
$0
Nov 13, 2019
Q2
2019
Jun 30, 2018
$0
Aug 13, 2019
Q1
2019
Mar 31, 2018
$0
May 14, 2019
Q3
2018
Sep 30, 2017
$0
Nov 9, 2018
Q2
2018
Jun 30, 2017
$0
Aug 14, 2018
Q1
2018
Mar 31, 2017
$0
May 11, 2018
Q3
2017
Sep 30, 2016
$26.0K
Dec 15, 2017
Q2
2017
Jun 30, 2016
$28.0K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$0
May 11, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$123.0K
Nov 7, 2025
Q2
2025
Jun 30, 2025
$317.0K
Aug 11, 2025
Q1
2025
Mar 31, 2025
$45.0K
May 14, 2025
Q3
2025
Sep 30, 2024
$59.0K
Nov 7, 2025
Q2
2025
Jun 30, 2024
$56.0K
Aug 11, 2025
Q1
2025
Mar 31, 2024
$57.0K
May 14, 2025
Q3
2024
Sep 30, 2023
$40.0K
Nov 13, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.70M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.82M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($1.66M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.86M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($2.50M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($2.03M)
May 14, 2025
Q3
2024
Sep 30, 2023
($1.62M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.61M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($2.89M)
May 13, 2024
Q3
2023
Sep 30, 2022
($1.06M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($1.35M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.18M)
May 12, 2023
Q3
2022
Sep 30, 2021
($849.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($382.0K)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($874.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($660.0K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.19M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($2.00M)
May 24, 2021
Q3
2020
Sep 30, 2019
($2.38M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($2.43M)
Aug 13, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.71M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.83M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($1.67M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.86M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($2.48M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($2.02M)
May 14, 2025
Q3
2024
Sep 30, 2023
($1.62M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.65M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($2.89M)
May 13, 2024
Q3
2023
Sep 30, 2022
($1.08M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($1.38M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.21M)
May 12, 2023
Q3
2022
Sep 30, 2021
($822.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($918.0K)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($995.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.06M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.26M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.90M)
May 24, 2021
Q3
2020
Sep 30, 2019
($2.50M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($2.67M)
Aug 13, 2020